AstraZeneca inks China AI research deal for chronic diseases

China News

AstraZeneca inks China AI research deal for chronic diseases

AstraZeneca inks China AI research deal for chronic diseases
by AFP Staff Writers
London (AFP) June 13, 2025

British drugmaker AstraZeneca unveiled on Friday an AI-assisted research partnership with Chinese counterpart CSPC Pharmaceuticals worth up to $5.3 billion to tackle chronic diseases.

AstraZeneca, which has a pre-existing collaboration with CSPC, announced earlier this year plans to invest $2.5 billion in China.

"This strategic research collaboration underscores our commitment to innovation to tackle chronic diseases which impact over two billion people globally," said AstraZeneca executive vice president Sharon Barr.

AstraZeneca aims to develop a research and development centre of up to 1,700 people in the country.

CSPC will carry out the research in Shijiazhuang, using "their AI-driven, dual-engine efficient drug discovery platform", the firm said.

AstraZeneca said the agreement will see CSPC receive an upfront payment of $110 million, plus up to $1.62 billion in "potential development milestone payments" and up to a further $3.6 billion in sales milestone payments, along with annual sales-based royalties.

The multinational will also be able to exercise options for exclusive licences to develop and commercialise worldwide candidates identified under the deal.

ode/zap/cw/djt/lth

ASTRAZENECA

Related Links
Hospital and Medical News at InternDaily.com

Subscribe Free To Our Daily Newsletters

RELATED CONTENT

The following news reports may link to other Space Media Network websites.

Regeneron to buy 23andMe out of bankruptcy for $256 mn
New York (AFP) May 19, 2025
Regeneron Pharmaceuticals said Monday it will buy genetic testing company 23andMe out of bankruptcy for $256 million, a deal that provides the US biotech company with data on millions of clients. New York-based Regeneron said it had been named the successful bidder in the bankruptcy auction for 23andMe, which has struggled with falling sales following a 2023 data breach that saw nearly seven million accounts affected. Regeneron CEO George Yancopoulos described his enterprise as "a science-driven ... read more

Chinese rocket delivers e-commerce packages in sea recovery test

China Establishes UN-SPIDER Regional Support Office at Wuhan University

Tiangong returns largest sample set yet for biological and materials science research

Space is a place to found a community not a colony

China's AliExpress risks fine for breaching EU illegal product rules

Monsters and memes: Labubu dolls ride China soft-power wave

Oil rises, dollar firms after US strikes in Iran

Japan, South Korea leaders vow to boost ties against nuclear-armed North

Dalai Lama to issue July 2 message, expected to address succession

Putin, Xi 'strongly condemn' Israeli strikes on Iran, urge diplomatic solution

Iran strikes Israel as Trump weighs US involvement

Kallas says Russia doesn't 'stand a chance' if NATO sticks 'together'; Putin says rearmament not a 'threat'

U.S. company to provide $6B loan for British nuclear power project

Nuclearn Deploys Gamma2 AI to Revolutionize Nuclear Plant Operations

Advancing fission dynamics understanding in mercury isotopes with 5D Langevin model

Blue Sky Uranium launches major drill initiative to fast-track Ivana project in Argentina

WhatsApp 'concerned' services to be blocked after Iran calls to delete app

Musk's X sues to block New York social media transparency law

Israel's strikes on Iran were years in the making: analysts

Ex-CIA analyst gets three years in prison for sharing top secret information

U.S. company to provide $6B loan for British nuclear power project

Nuclearn Deploys Gamma2 AI to Revolutionize Nuclear Plant Operations

Advancing fission dynamics understanding in mercury isotopes with 5D Langevin model

Blue Sky Uranium launches major drill initiative to fast-track Ivana project in Argentina

Thailand credits prey releases for 'extraordinary' tiger recovery

Trump admin ends halt on New York offshore wind project

Trump shift boosts offshore wind project: New York governor

Norway's Equinor slams 'unlawful' halt to US wind farm

Subscribe Free To Our Daily Newsletters

The content herein, unless otherwise known to be public domain, are Copyright 1995-2024 - Space Media Network. All websites are published in Australia and are solely subject to Australian law and governed by Fair Use principals for news reporting and research purposes. AFP, UPI and IANS news wire stories are copyright Agence France-Presse, United Press International and Indo-Asia News Service. ESA news reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. All articles labeled "by Staff Writers" include reports supplied to Space Media Network by industry news wires, PR agencies, corporate press officers and the like. Such articles are individually curated and edited by Space Media Network staff on the basis of the report's information value to our industry and professional readership. Advertising does not imply endorsement, agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. General Data Protection Regulation (GDPR) Statement Our advertisers use various cookies and the like to deliver the best ad banner available at one time. All network advertising suppliers have GDPR policies (Legitimate Interest) that conform with EU regulations for data collection. By using our websites you consent to cookie based advertising. If you do not agree with this then you must stop using the websites from May 25, 2018. Privacy Statement. Additional information can be found here at About Us.